Whole‐body diffusion‐weighted magnetic resonance imaging: Diagnosis and follow up of prostate cancer and beyond

• 資料種別: 記事
• タイトル: Whole‐body diffusion‐weighted magnetic resonance imaging: Diagnosis and follow up of prostate cancer and beyond
• 著者標目: Soichiro Yoshida; https://orcid.org/0000-0003-2757-8083; Taro Takahara; Yuki Arita; https://orcid.org/0000-0002-5285-0352; Shinjiro Sakaino; Kazuhiro Katahira; Yasuhisa Fujii
• 出版年月日等: 2021-03-06
• 出版年（W3CDTF）: 2021-03-06
• タイトル（掲載誌）: International Journal of Urology
• 巻号年月日等（掲載誌）: 28 5
• 掲載巻: 28
• 掲載号: 5
• 掲載ページ: 502-513
• 掲載年月日（W3CDTF）: 2021-03-06
• ISSN（掲載誌）: 09198172
• 出版事項（掲載誌）: Wiley
• 件名標目: Male; Diffusion Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Humans; Prostatic Neoplasms; Whole Body Imaging; Magnetic Resonance Imaging; Follow-Up Studies
• 対象利用者: 一般
• 標準番号（その他）: PMID : 33676376
• DOI: 10.1111/iju.14497
• 作成日（W3CDTF）: 2021-03-06
• 著作権情報: http://onlinelibrary.wiley.com/termsAndConditions#vor
• 関連情報（URI）: https://onlinelibrary.wiley.com/doi/pdf/10.1111/iju.14497; https://onlinelibrary.wiley.com/doi/full-xml/10.1111/iju.14497; https://search.jamas.or.jp/link/ui/2022035519
• 参照: Low-Field Magnetic Resonance Imaging; https://cir.nii.ac.jp/crid/1360013168752915456; Novel quantitative software for automatically excluding red bone marrow on whole‐body magnetic resonance imaging in patients with metastatic prostate cancer: A pilot study; https://cir.nii.ac.jp/crid/1360021390561467136
• 参照: Prostate-Specific Antigen (PSA) as a Surrogate End Point for Survival in Prostate Cancer Clinical Trials; https://cir.nii.ac.jp/crid/1360011143663009664; Combined Ultrasmall Superparamagnetic Particles of Iron Oxide–Enhanced and Diffusion-weighted Magnetic Resonance Imaging Facilitates Detection of Metastases in Normal-sized Pelvic Lymph Nodes of Patients with Bladder and Prostate Cancer; https://cir.nii.ac.jp/crid/1360011144910047616; Whole-body MRI using a sliding table and repositioning surface coil approach; https://cir.nii.ac.jp/crid/1360292621059540992; Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer; https://cir.nii.ac.jp/crid/1360292621303147648; Utility of computed diffusion‐weighted MRI for predicting aggressiveness of prostate cancer; https://cir.nii.ac.jp/crid/1360567180139063680; METastasis Reporting and Data System for Prostate Cancer as a Prognostic Imaging Marker in Castration-resistant Prostate Cancer; https://cir.nii.ac.jp/crid/1360572092519458432; 68Ga-PSMA-PET/CT in comparison with 18F-fluoride-PET/CT and whole-body MRI for the detection of bone metastases in patients with prostate cancer: a prospective diagnostic accuracy study; https://cir.nii.ac.jp/crid/1360574094003163136; ⁶⁸Ga-PSMA-11 PET Imaging of Response to Androgen Receptor Inhibition: First Human Experience; https://cir.nii.ac.jp/crid/1360574094167592832; Distribution of metastatic sites in patients with prostate cancer: A population‐based analysis; https://cir.nii.ac.jp/crid/1360574094922882816; Bone Abnormal Signal Incidentally Found in Pre-Biopsy Diffusion-Weighted MRI for Suspected Prostate Cancer: What Does It Reflect?; https://cir.nii.ac.jp/crid/1360574095275197056; Multiparametric MRI for detection of radiorecurrent prostate cancer: added value of apparent diffusion coefficient maps and dynamic contrast-enhanced images; https://cir.nii.ac.jp/crid/1360845539037686144; Computed diffusion-weighted imaging using 3-T magnetic resonance imaging for prostate cancer diagnosis; https://cir.nii.ac.jp/crid/1360855569573692800; Current and potential future role of PSMA-PET in patients with castration-resistant prostate cancer; https://cir.nii.ac.jp/crid/1360855569971445376; Whole-Body Diffusion-Weighted MRI: Tips, Tricks, and Pitfalls; https://cir.nii.ac.jp/crid/1360855570057617152; One‐step TNM staging of high‐risk prostate cancer using magnetic resonance imaging (MRI): Toward an upfront simplified “all‐in‐one” imaging approach?; https://cir.nii.ac.jp/crid/1360855570959692672; Progressive Site-Directed Therapy for Castration-Resistant Prostate Cancer: Localization of the Progressive Site as a Prognostic Factor; https://cir.nii.ac.jp/crid/1361131416840014848; Comparison of PSMA-PET/CT, choline-PET/CT, NaF-PET/CT, MRI, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a systematic review and meta-analysis; https://cir.nii.ac.jp/crid/1361137043530141824; Imaging of prostate cancer local recurrences: why and how?; https://cir.nii.ac.jp/crid/1361137044675244160; Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging.; https://cir.nii.ac.jp/crid/1361137046490264192; Whole body MRI: Improved lesion detection and characterization with diffusion weighted techniques; https://cir.nii.ac.jp/crid/1361418518496078848; Diffusion-Weighted MRI in the Body: Applications and Challenges in Oncology; https://cir.nii.ac.jp/crid/1361418519944032384; Monitoring the response of bone metastases to treatment with Magnetic Resonance Imaging and nuclear medicine techniques: A review and position statement by the European Organisation for Research and Treatment of Cancer imaging group; https://cir.nii.ac.jp/crid/1361418519985442560; Assessing response to treatment of bone metastases from breast cancer: what should be the standard of care?; https://cir.nii.ac.jp/crid/1361418519997921792; Management of Node Only Recurrence after Primary Local Treatment for Prostate Cancer: A Systematic Review of the Literature; https://cir.nii.ac.jp/crid/1361418520067317248; Carbon 11-choline positron emission tomography/computed tomography and palliative local therapy for castration-resistant prostate cancer; https://cir.nii.ac.jp/crid/1361418520150673280; Prospective comparison of whole-body MRI and 68Ga-PSMA PET/CT for the detection of biochemical recurrence of prostate cancer after radical prostatectomy; https://cir.nii.ac.jp/crid/1361418520778951680; Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019; https://cir.nii.ac.jp/crid/1361694366709449984; Prospective Evaluation of 11C-Choline Positron Emission Tomography/Computed Tomography and Diffusion-Weighted Magnetic Resonance Imaging for the Nodal Staging of Prostate Cancer with a High Risk of Lymph Node Metastases; https://cir.nii.ac.jp/crid/1361699993589177088; Can Whole-body Magnetic Resonance Imaging with Diffusion-weighted Imaging Replace Tc 99m Bone Scanning and Computed Tomography for Single-step Detection of Metastases in Patients with High-risk Prostate Cancer?; https://cir.nii.ac.jp/crid/1361699994173832960; Volume of Bone Metastasis Assessed with Whole-Body Diffusion-weighted Imaging Is Associated with Overall Survival in Metastatic Castration-resistant Prostate Cancer; https://cir.nii.ac.jp/crid/1361699994470459136; MRI in the detection of malignant infiltration of bone marrow; https://cir.nii.ac.jp/crid/1361699995670364160; Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial; https://cir.nii.ac.jp/crid/1361699996021909760; Whole-Body Diffusion-Weighted MRI Compared With ¹⁸F-NaF PET/CT for Detection of Bone Metastases in Patients With High-Risk Prostate Carcinoma; https://cir.nii.ac.jp/crid/1361981468774701184; Preliminary Results for Characterization of Pelvic Lymph Nodes in Patients With Prostate Cancer by Diffusion-Weighted MR-Imaging; https://cir.nii.ac.jp/crid/1361981469220112000; Quantitative assessment of intracranial tumor response to dexamethasone using diffusion, perfusion and permeability magnetic resonance imaging; https://cir.nii.ac.jp/crid/1361981469311628288; Visceral Disease in Castration-resistant Prostate Cancer; https://cir.nii.ac.jp/crid/1361981470392857216; New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1); https://cir.nii.ac.jp/crid/1361981470781131776; Malignant Cervical Lymphadenopathy: Diagnostic Accuracy of Diffusion-weighted MR Imaging; https://cir.nii.ac.jp/crid/1361981470790121600; Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer; https://cir.nii.ac.jp/crid/1361981471145290368; Guidelines for resection of colorectal cancer liver metastases; https://cir.nii.ac.jp/crid/1362262943336000384; Principles of whole‐body continuously‐moving‐table MRI; https://cir.nii.ac.jp/crid/1362262943389469312; Detection of locally radio-recurrent prostate cancer at multiparametric MRI: Can dynamic contrast-enhanced imaging be omitted?; https://cir.nii.ac.jp/crid/1362262943617091712; Whole-body MRI (WB-MRI) versus axial skeleton MRI (AS-MRI) to detect and measure bone metastases in prostate cancer (PCa); https://cir.nii.ac.jp/crid/1362262944363114496; Whole-body MRI to assess bone involvement in prostate cancer and multiple myeloma: comparison of the diagnostic accuracies of the T1, short tau inversion recovery (STIR), and high b-values diffusion-weighted imaging (DWI) sequences; https://cir.nii.ac.jp/crid/1362262945199810176; Multiparametric whole-body 3.0-T MRI in newly diagnosed intermediate- and high-risk prostate cancer: diagnostic accuracy and interobserver agreement for nodal and metastatic staging; https://cir.nii.ac.jp/crid/1362262945966698752; Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology; https://cir.nii.ac.jp/crid/1362262946422468992; Prospective Comparison of ^99mTc-MDP Scintigraphy, Combined ¹⁸F-NaF and ¹⁸F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer; https://cir.nii.ac.jp/crid/1362544419402034304; Computed diffusion-weighted imaging of the prostate at 3 T: impact on image quality and tumour detection; https://cir.nii.ac.jp/crid/1362544419689537280; MR Microimaging of Benign and Malignant Nodes in the Neck; https://cir.nii.ac.jp/crid/1362544420341490432; Pilot study on the detection of antiandrogen resistance using serial diffusion‐weighted imaging of bone metastases in prostate cancer; https://cir.nii.ac.jp/crid/1362544420819233536; Diffusion-Weighted Magnetic Resonance Imaging of the Liver Using TRacking Only Navigator Echo; https://cir.nii.ac.jp/crid/1362825893323568384; Computed Diffusion-weighted MR Imaging May Improve Tumor Detection; https://cir.nii.ac.jp/crid/1362825893623361920; Diffusion-weighted MR Imaging of the Brain; https://cir.nii.ac.jp/crid/1362825894335111296; Restricted Water Diffusibility as Measured by Diffusion-weighted MR Imaging and Choline Uptake in 11C-Choline PET/CT are Correlated in Pelvic Lymph Nodes in Patients with Prostate Cancer; https://cir.nii.ac.jp/crid/1362825895566036864; Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer; https://cir.nii.ac.jp/crid/1363107368557135744; Combined Ultrasmall Superparamagnetic Particles of Iron Oxide–Enhanced and Diffusion-Weighted Magnetic Resonance Imaging Reliably Detect Pelvic Lymph Node Metastases in Normal-Sized Nodes of Bladder and Prostate Cancer Patients; https://cir.nii.ac.jp/crid/1363107368733535488; Whole-Body Bone Marrow MRI in Patients with Metastatic Disease to the Skeletal System; https://cir.nii.ac.jp/crid/1363107368799412864; Progression-free Survival Following Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Treatment-naive Recurrence: A Multi-institutional Analysis; https://cir.nii.ac.jp/crid/1363107371029982592; METastasis Reporting and Data System for Prostate Cancer: Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate Cancer; https://cir.nii.ac.jp/crid/1363388844021879040; Whole-Body MR Imaging: Evaluation of Patients for Metastases; https://cir.nii.ac.jp/crid/1363388845219776000; Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3; https://cir.nii.ac.jp/crid/1363670318261850880; Localising occult prostate cancer metastasis with advanced imaging techniques (LOCATE trial): a prospective cohort, observational diagnostic accuracy trial investigating whole–body magnetic resonance imaging in radio-recurrent prostate cancer; https://cir.nii.ac.jp/crid/1363670318437324672; Role of metastasectomy for metastatic renal cell carcinoma in the era of targeted therapy; https://cir.nii.ac.jp/crid/1363670318606559360; Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer; https://cir.nii.ac.jp/crid/1363670319041698176; A comparison of whole-body turboSTIR MR imaging and planar 99mTc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases.; https://cir.nii.ac.jp/crid/1363670319160041216; WHOLE BODY DWIBS MRI VERSUS BONE SCAN FOR EVALUATING SKELETAL METASTASES; https://cir.nii.ac.jp/crid/1363670319760170240; Inter- and Intra-Observer Repeatability of Quantitative Whole-Body, Diffusion-Weighted Imaging (WBDWI) in Metastatic Bone Disease; https://cir.nii.ac.jp/crid/1363670320205193728; Magnetic resonance imaging for the diagnosis of prostate cancer metastatic to bone; https://cir.nii.ac.jp/crid/1363670320232455680; Oligometastases.; https://cir.nii.ac.jp/crid/1363670320602449152; Complementary Roles of Whole-Body Diffusion-Weighted MRI and¹⁸F-FDG PET: The State of the Art and Potential Applications; https://cir.nii.ac.jp/crid/1363670320784516352; Multiparametric Prostate MR Imaging with T2-weighted, Diffusion-weighted, and Dynamic Contrast-enhanced Sequences: Are All Pulse Sequences Necessary to Detect Locally Recurrent Prostate Cancer after Radiation Therapy?; https://cir.nii.ac.jp/crid/1363951794069948416; Whole body turbo STIR MRI in unknown primary tumor detection; https://cir.nii.ac.jp/crid/1363951794142194048; Diffusion-Weighted Magnetic Resonance Imaging as a Cancer Biomarker: Consensus and Recommendations; https://cir.nii.ac.jp/crid/1363951794471420544; Diffusion‐weighted MR imaging of the liver at 3.0 Tesla using TRacking Only Navigator echo (TRON): A feasibility study; https://cir.nii.ac.jp/crid/1363951794852469248; Whole-body MRI using a rolling table platform for the detection of bone metastases; https://cir.nii.ac.jp/crid/1364233268394036608; Magnetic Resonance Imaging of the Axial Skeleton for Detecting Bone Metastases in Patients With High-Risk Prostate Cancer: Diagnostic and Cost-Effectiveness and Comparison With Current Detection Strategies; https://cir.nii.ac.jp/crid/1364233268781362944; Metastasis-directed Therapy of Regional and Distant Recurrences After Curative Treatment of Prostate Cancer: A Systematic Review of the Literature; https://cir.nii.ac.jp/crid/1364233268890764928; Continuously moving table data acquisition method for long FOV contrast‐enhanced MRA and whole‐body MRI; https://cir.nii.ac.jp/crid/1364233270347536768; “MRI in the Detection of Malignant Infiltration of Bone Marrow”—A Commentary; https://cir.nii.ac.jp/crid/1364233271179915904; A Prospective comparison of (18)F‐prostate‐specific membrane antigen‐1007 positron emission tomography computed tomography, whole‐body 1.5 T magnetic resonance imaging with diffusion‐weighted imaging, and single‐photon emission computed tomography/computed tomography with traditional imaging in primary distant metastasis staging of prostate cancer (PROSTAGE); https://cir.nii.ac.jp/crid/1370016863372001664; Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display; https://cir.nii.ac.jp/crid/1370572092520397195; Whole Body MRI for Detecting Metastatic Bone Tumor: Comparison with Bone Scintigrams; https://cir.nii.ac.jp/crid/1390282680171277696; Discrimination of metastatic cervical lymph nodes with diffusion‐weighted MR imaging in patients with head and neck cancer; https://cir.nii.ac.jp/crid/1572543024785913600
• 連携機関・データベース: 国立情報学研究所 : CiNii Research; https://cir.nii.ac.jp/
• 提供元機関・データベース: Crossref; https://www.crossref.org; 科学研究費助成事業データベース; https://kaken.nii.ac.jp/ja

• 要約等: <jats:title>Abstract</jats:title><jats:p>The diffusion‐weighted imaging signal is derived from the motion of water molecules. It represents the physio...